Back to top

earnings-consensus: Archive

Zacks Equity Research

Wall Street Analysts See a 42.78% Upside in Keros Therapeutics (KROS): Can the Stock Really Move This High?

The consensus price target hints at a 42.8% upside potential for Keros Therapeutics (KROS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

KROSNegative Net Change

Zacks Equity Research

Does Pharming Group (PHAR) Have the Potential to Rally 100.91% as Wall Street Analysts Expect?

The mean of analysts' price targets for Pharming Group (PHAR) points to a 100.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

PHARNegative Net Change

Zacks Equity Research

Wall Street Analysts Believe PRA Group (PRAA) Could Rally 53.69%: Here's is How to Trade

The mean of analysts' price targets for PRA Group (PRAA) points to a 53.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

PRAAPositive Net Change

Zacks Equity Research

Wall Street Analysts See a 75.15% Upside in Orion Energy Systems (OESX): Can the Stock Really Move This High?

The consensus price target hints at a 75.2% upside potential for Orion Energy Systems (OESX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

OESXPositive Net Change

Zacks Equity Research

Wall Street Analysts Predict a 35.5% Upside in SkyWest (SKYW): Here's What You Should Know

The average of price targets set by Wall Street analysts indicates a potential upside of 35.5% in SkyWest (SKYW). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

SKYWNegative Net Change

Zacks Equity Research

Wall Street Analysts Predict a 45.88% Upside in OppFi (OPFI): Here's What You Should Know

The average of price targets set by Wall Street analysts indicates a potential upside of 45.9% in OppFi (OPFI). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

OPFIPositive Net Change

Zacks Equity Research

How Much Upside is Left in Alto Neuroscience, Inc. (ANRO)? Wall Street Analysts Think 61.99%

The consensus price target hints at a 62% upside potential for Alto Neuroscience, Inc. (ANRO). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

ANROPositive Net Change

Zacks Equity Research

Does Onestream (OS) Have the Potential to Rally 25.9% as Wall Street Analysts Expect?

The average of price targets set by Wall Street analysts indicates a potential upside of 25.9% in Onestream (OS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

OSPositive Net Change

Zacks Equity Research

Wall Street Analysts Believe OrthoPediatrics (KIDS) Could Rally 41.92%: Here's is How to Trade

The consensus price target hints at a 41.9% upside potential for OrthoPediatrics (KIDS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

KIDSNegative Net Change

Zacks Equity Research

Wall Street Analysts Believe Omnicell (OMCL) Could Rally 34.53%: Here's is How to Trade

The consensus price target hints at a 34.5% upside potential for Omnicell (OMCL). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

OMCLNegative Net Change

Zacks Equity Research

Will Spire (SR) Report Negative Earnings Next Week? What You Should Know

Spire (SR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

SRNegative Net Change

Zacks Equity Research

Wall Street Analysts See a 27.15% Upside in Great Lakes Dredge & Dock (GLDD): Can the Stock Really Move This High?

The mean of analysts' price targets for Great Lakes Dredge & Dock (GLDD) points to a 27.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

GLDDNegative Net Change

Zacks Equity Research

Wall Street Analysts Predict a 26.21% Upside in Crown (CCK): Here's What You Should Know

The average of price targets set by Wall Street analysts indicates a potential upside of 26.2% in Crown (CCK). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

CCKNegative Net Change

Zacks Equity Research

Does Alkermes (ALKS) Have the Potential to Rally 36.3% as Wall Street Analysts Expect?

The consensus price target hints at a 36.3% upside potential for Alkermes (ALKS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

ALKSNegative Net Change

Zacks Equity Research

Wall Street Analysts Believe DAVE INC (DAVE) Could Rally 35.43%: Here's is How to Trade

The consensus price target hints at a 35.4% upside potential for DAVE INC (DAVE). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

DAVENegative Net Change

Zacks Equity Research

Wall Street Analysts Think Stagwell (STGW) Could Surge 37.54%: Read This Before Placing a Bet

The average of price targets set by Wall Street analysts indicates a potential upside of 37.5% in Stagwell (STGW). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

STGWNegative Net Change

Zacks Equity Research

Wall Street Analysts Think Veritone (VERI) Could Surge 65.88%: Read This Before Placing a Bet

The mean of analysts' price targets for Veritone (VERI) points to a 65.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

VERIPositive Net Change

Zacks Equity Research

Does MediaAlpha (MAX) Have the Potential to Rally 25.33% as Wall Street Analysts Expect?

The mean of analysts' price targets for MediaAlpha (MAX) points to a 25.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

MAXNegative Net Change

Zacks Equity Research

Earnings Preview: Intuitive Machines, Inc. (LUNR) Q3 Earnings Expected to Decline

Intuitive Machines, Inc. (LUNR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

LUNRPositive Net Change SAROPositive Net Change

Zacks Equity Research

OneWater Marine (ONEW) Reports Next Week: Wall Street Expects Earnings Growth

OneWater Marine (ONEW) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ONEWNegative Net Change

Zacks Equity Research

Sunrise Realty Trust, Inc. (SUNS) Earnings Expected to Grow: Should You Buy?

Sunrise Realty Trust, Inc. (SUNS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

SUNSPositive Net Change RMRNegative Net Change

Zacks Equity Research

Analysts Estimate Cracker Barrel Old Country Store (CBRL) to Report a Decline in Earnings: What to Look Out for

Cracker Barrel (CBRL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CBRLNegative Net Change RRGBNegative Net Change

Zacks Equity Research

Envoy Medical, Inc. (COCH) Expected to Beat Earnings Estimates: Should You Buy?

Envoy Medical, Inc. (COCH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

COCHPositive Net Change MASSNegative Net Change

Zacks Equity Research

Globant (GLOB) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

Globant (GLOB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

GLOBNegative Net Change

Zacks Equity Research

Luminar Technologies, Inc. (LAZR) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

Luminar Technologies (LAZR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

LAZRNegative Net Change EVGONegative Net Change